Cell-Mediated Immune Response (CMI) and Organ Transplantation
While antibodies (the humoral immune response) are highly effective against pathogens floating freely in the blood and body fluids, they cannot reach pathogens that have already hidden inside the host’s cells. This is where the second branch of the acquired immune system, the Cell-Mediated Immune Response (CMI), takes over.
Mechanism of Cell-Mediated Immunity
CMI is entirely managed by T-lymphocytes (T-cells). Unlike B-cells, T-cells do not
Cell-Mediated Immune Response (CMI) and Organ Transplantation
- Function: CMI targets pathogens that hide inside the host’s cells, where circulating antibodies (humoral immunity) cannot reach them.
- Primary Cells: This entire response is managed by T-lymphocytes (T-cells).
- Direct Combat: Unlike B-cells, T-cells do not produce antibodies. They engage in direct physical combat to destroy threats.
- Self vs. Non-Self Recognition: T-cells possess a critical biological ability to differentiate between the body’s own healthy tissues (“self”) and foreign, infected, or abnormal cells (“non-self”).
- Destruction Process: When a human cell is infected by a virus or turns cancerous, it displays foreign antigens on its surface. Active T-cells identify these markers, bind to the infected cell, and release chemicals that completely destroy it.
The Challenge of Organ Transplantation
- Medical Requirement: Surgical transplantation is often the final remedy to save a life when vital organs (like the heart, liver, or kidneys) fail entirely due to injury or disease.
- The Immune Hurdle: A patient cannot accept an organ from any random donor.
- T-Cell Surveillance: Because patrolling T-lymphocytes are programmed to attack anything foreign, they immediately recognize the transplanted organ as “non-self” tissue.
Graft Rejection and Medical Management
- Graft Rejection: This is the severe biological reaction where the Cell-Mediated Immune Response launches a massive attack to rapidly destroy the newly transplanted organ.
- Prevention Protocols: Doctors follow strict medical procedures to prevent this life-threatening rejection.
- Tissue Matching: Before surgery, extensive blood group matching and tissue protein matching are conducted between the donor and recipient to find the closest biological match.
- Immunosuppressant Drugs: Even with a highly successful match, the patient’s immune system will still perceive the new organ as slightly foreign.
- Lifelong Medication: To ensure the organ survives, the patient must take specialized medicines called immunosuppressants for the rest of their life. These drugs artificially “quiet down” the CMI, stopping T-cells from attacking the graft.
